Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 5/20 | 0.55 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | GNPAT | O15228 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.51 |
| ▸ | GRM8 | O00222 | 1/20 | 0.50 |
| ▸ | GRM6 | O15303 | 1/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.50 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 1/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.50 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.50 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28486153 | 1.00 | FOLH1 (0.55) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL31448323 | 0.98 | FOLH1 (0.53) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL30607422 | 0.98 | FOLH1 (0.53) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL30099544 | 0.95 | DPP4 (0.50) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL30099651 | 0.95 | DPP4 (0.50) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL30020165 | 0.95 | DPP4 (0.50) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL30099498 | 0.95 | DPP4 (0.50) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL30099554 | 0.95 | DPP4 (0.50) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL31453847 | 0.95 | DPP4 (0.50) | FOLH1RIMKLANAALAD2GNPATDPP4 | |
| SCHEMBL31287182 | 0.95 | DPP4 (0.53) | FOLH1RIMKLANAALAD2GNPATDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4490175-A2 | VEGF-C MUTEINS FOR SELECTIVE LYMPHATIC STIMULATION | Yale University (US) | 2025-01-15 | — | — | EP | disclosed |
| WO-2024168252-A2 | USE OF INHIBITORS OF VEGF-C SIGNALING FOR INHIBITING IMMUNE RESPONSES AND INCREASING GENE THERAPY EFFICACY | YALE UNIVERSITY (US) | 2024-08-15 | — | — | WO | disclosed |
| WO-2024073025-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| CN-112125821-B | Aqueous solution containing N-long-chain acyl acidic amino acid and/or salt thereof and method for producing same | 味之素株式会社 | 2024-02-20 | — | — | CN | disclosed |
| WO-2023172964-A2 | VEGF-C MUTEINS FOR SELECTIVE LYMPHATIC STIMULATION | YALE UNIVERSITY (US) | 2023-09-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | FOLH1 3290/4885RIMKLA 3443/4885NAALAD2 1981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.